{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T00:57:07Z","timestamp":1768093027382,"version":"3.49.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["2018R1D1A3B07043344"],"award-info":[{"award-number":["2018R1D1A3B07043344"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","award":["2017R1C1B1006717"],"award-info":[{"award-number":["2017R1C1B1006717"]}],"id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.ijcard.2019.11.086","type":"journal-article","created":{"date-parts":[[2019,11,8]],"date-time":"2019-11-08T21:13:40Z","timestamp":1573247620000},"page":"35-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Comparison between angiotensin-converting enzyme inhibitor and angiotensin receptor blocker after percutaneous coronary intervention"],"prefix":"10.1016","volume":"306","author":[{"given":"Soe Hee","family":"Ann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin H.","family":"Strauss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gyung-Min","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seungbong","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yujin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong-Giun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ki-Bum","family":"Won","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin-Jae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Gon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young-Rak","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dae-Won","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahn-Won","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung Ho","family":"Her","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung-Whan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2019.11.086_bb0005","unstructured":"S.D. Fihn, J.M. Gardin, J. Abrams, et al., 2012 ACCF\/AHA\/ACP\/AATS\/PCNA\/SCAI\/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons, J Am Coll Cardiol 60 (2012) e44-e164."},{"key":"10.1016\/j.ijcard.2019.11.086_bb0010","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1093\/eurheartj\/ehu278","volume":"35","author":"m. Authors\/Task Force","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ijcard.2019.11.086_bb0015","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1161\/CIRCULATIONAHA.114.013042","volume":"131","author":"Iqbal","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2019.11.086_bb0020","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1016\/j.jacc.2005.06.070","article-title":"Application of evidence-based medical therapy is associated with improved outcomes after percutaneous coronary intervention and is a valid quality indicator","volume":"46","author":"Jaber","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2019.11.086_bb0025","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1056\/NEJMoa1002358","article-title":"A prospective natural-history study of coronary atherosclerosis","volume":"364","author":"Stone","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2019.11.086_bb0030","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1056\/NEJM199606203342507","article-title":"Angiotensin receptors and their antagonists","volume":"334","author":"Goodfriend","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2019.11.086_bb0035","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1097\/HJH.0b013e3280bad9b4","article-title":"Blood pressure-dependent and independent effects of agents that inhibit the renin-angiotensin system","volume":"25","author":"Turnbull","year":"2007","journal-title":"J. Hypertens."},{"key":"10.1016\/j.ijcard.2019.11.086_bb0040","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1161\/HYPERTENSIONAHA.118.10266","article-title":"Understanding angiotensin II type 1 receptor signaling in vascular pathophysiology","volume":"71","author":"Eguchi","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.ijcard.2019.11.086_bb0045","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJM199209033271001","article-title":"Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE investigators","volume":"327","author":"Pfeffer","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2019.11.086_bb0050","doi-asserted-by":"crossref","unstructured":"W.E. Boden, R.A. O'Rourke, K.K. Teo, et al., Optimal medical therapy with or without PCI for stable coronary disease, N. Engl. J. Med. 356 (2007) 1503\u20131516..","DOI":"10.1056\/NEJMoa070829"},{"key":"10.1016\/j.ijcard.2019.11.086_bb0055","first-page":"782","volume":"vol. 362","year":"2003"},{"key":"10.1016\/j.ijcard.2019.11.086_bb0060","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa0801317","article-title":"Telmisartan, ramipril, or both in patients at high risk for vascular events","volume":"358","author":"Yusuf","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2019.11.086_bb0065","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0140-6736(02)09895-1","article-title":"Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial","volume":"360","author":"Dickstein","year":"2002","journal-title":"Lancet"},{"issue":"2013","key":"10.1016\/j.ijcard.2019.11.086_bb0070","first-page":"2949","article-title":"ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology","volume":"34","author":"Montalescot","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2019.11.086_bb0075","article-title":"ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"61","author":"O'Gara","year":"2013","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2019.11.086_bb0080","doi-asserted-by":"crossref","unstructured":"E.A. Amsterdam, N.K. Wenger, R.G. Brindis, et al., 2014 AHA\/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines, J Am Coll Cardiol 64 (e139-e228). https:\/\/doi.org\/10.1016\/j.jacc.2014.09.017.","DOI":"10.1016\/j.jacc.2014.09.017"},{"issue":"2016","key":"10.1016\/j.ijcard.2019.11.086_bb0085","first-page":"267","volume":"37","author":"Roffi","year":"2015","journal-title":"Eur. Heart J."},{"issue":"2018","key":"10.1016\/j.ijcard.2019.11.086_bb0090","first-page":"119","volume":"39","author":"Ibanez","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2019.11.086_bb0095","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1161\/CIRCOUTCOMES.114.001305","article-title":"Model for assessing cardiovascular risk in a Korean population","volume":"7","author":"Park","year":"2014","journal-title":"Circulation. Cardiovascular quality and outcomes"},{"key":"10.1016\/j.ijcard.2019.11.086_bb0100","doi-asserted-by":"crossref","first-page":"310","DOI":"10.4070\/kcj.2017.0359","article-title":"Trends, characteristics, and clinical outcomes of patients undergoing percutaneous coronary intervention in Korea between 2011 and 2015","volume":"48","author":"Han","year":"2018","journal-title":"Korean Circ J"},{"key":"10.1016\/j.ijcard.2019.11.086_bb0105","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"Quan","year":"2005","journal-title":"Med. Care"},{"key":"10.1016\/j.ijcard.2019.11.086_bb0110","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.2967\/jnumed.115.169318","article-title":"Anatomic or functional evaluation as an initial test for stable coronary artery disease: a propensity score analysis","volume":"57","author":"Park","year":"2016","journal-title":"J. Nucl. Med."},{"key":"10.1016\/j.ijcard.2019.11.086_bb0115","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g6650","article-title":"Angiotensin receptor blocker in patients with ST segment elevation myocardial infarction with preserved left ventricular systolic function: prospective cohort study","volume":"349","author":"Yang","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.ijcard.2019.11.086_bb0120","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s40256-015-0140-5","volume":"15","author":"Song","year":"2015","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"10.1016\/j.ijcard.2019.11.086_bb0125","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ijcard.2017.08.030","article-title":"Angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers in acute ST-segment elevation myocardial infarction patients with diabetes mellitus undergoing percutaneous coronary intervention","volume":"249","author":"Choi","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2019.11.086_bb0130","article-title":"Angiotensin-converting enzyme inhibitors provide better long-term survival benefits to patients with ami than angiotensin II receptor blockers after survival hospital discharge","author":"Choi","year":"2018","journal-title":"J. Cardiovasc. Pharmacol. Ther."},{"key":"10.1016\/j.ijcard.2019.11.086_bb0135","doi-asserted-by":"crossref","first-page":"d2234","DOI":"10.1136\/bmj.d2234","article-title":"Angiotensin receptor blockers and risk of myocardial infarction: meta-analyses and trial sequential analyses of 147 020 patients from randomised trials","volume":"342","author":"Bangalore","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.ijcard.2019.11.086_bb0140","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1161\/CIRCULATIONAHA.117.026112","article-title":"Angiotensin receptor blockers do not reduce risk of myocardial infarction, cardiovascular death, or total mortality: further evidence for the ARB-MI paradox","volume":"135","author":"Strauss","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2019.11.086_bb0145","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.pcad.2015.11.004","article-title":"The divergent cardiovascular effects of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on myocardial infarction and death","volume":"58","author":"Strauss","year":"2016","journal-title":"Prog. Cardiovasc. Dis."},{"key":"10.1016\/j.ijcard.2019.11.086_bb0150","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s40256-016-0185-0","article-title":"Effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on prothrombotic processes and myocardial infarction risk","volume":"16","author":"Dezsi","year":"2016","journal-title":"Am. J. Cardiovasc. Drugs"},{"key":"10.1016\/j.ijcard.2019.11.086_bb0155","first-page":"1408","article-title":"Length of initial prescription at hospital discharge and long-term medication adherence for elderly patients with coronary artery disease: a population-level study","volume":"29","author":"Ivers","year":"2013","journal-title":"The Canadian journal of cardiology"},{"key":"10.1016\/j.ijcard.2019.11.086_bb0160","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jacc.2014.09.088","article-title":"Underutilization of high-intensity statin therapy after hospitalization for coronary heart disease","volume":"65","author":"Rosenson","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2019.11.086_bb0165","article-title":"Long versus short dual antiplatelet therapy in acute coronary syndrome patients treated with prasugrel or ticagrelor and coronary revascularization: insights from the RENAMI registry","volume":"2047487319836327","author":"D\u2019Ascenzo","year":"2019","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10.1016\/j.ijcard.2019.11.086_bb0170","doi-asserted-by":"crossref","first-page":"2702","DOI":"10.1161\/CIRCULATIONAHA.108.790048","article-title":"Cardiovascular disease and risk factors in Asia: a selected review","volume":"118","author":"Ueshima","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2019.11.086_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.amjcard.2014.03.055","article-title":"Comparison of 5-year survival after acute myocardial infarction using angiotensin-converting enzyme inhibitor versus angiotensin II receptor blocker","volume":"114","author":"Hara","year":"2014","journal-title":"Am. J. Cardiol."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527319322752?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527319322752?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:47:20Z","timestamp":1759092440000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527319322752"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":35,"alternative-id":["S0167527319322752"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2019.11.086","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison between angiotensin-converting enzyme inhibitor and angiotensin receptor blocker after percutaneous coronary intervention","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2019.11.086","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}